Melissa Matson

Statistics

Publications

Citations

H-Index

Active since

2017

Affiliations

University of North Carolina at Chapel Hill(Current)

UNC Lineberger Comprehensive Cancer Center

Sidney Kimmel Comprehensive Cancer Center

Johns Hopkins University

Melissa Matson is an author at University of North Carolina at Chapel Hill specializing in refractory leukemia, chemotherapy, and cytarabine-based regimens.

Publications per year

2017–2023

Publications

Final Clinical Results of a Phase II Study of High Dose Cytarabine Followed By Pembrolizumab in Relapsed/Refractory AML

Joshua F. Zeidner, Benjamin G. Vincent, Sonia Esparza et al. · Blood · 2019 · 33 citations

Medicine, Oncology, Pharmacology +11

Health Insurance Payer Type and Ethnicity Are Associated with Cancer Clinical Trial Enrollment Among Adolescents and Young Adults

Rebecca D Sullenger, Allison M. Deal, Juneko E. Grilley Olson et al. · Journal of Adolescent and Young Adult Oncology · 2021 · 15 citations · Full text

Medicine, Oncology, Adolescent Health +16

Developing a Comprehensive Adolescent and Young Adult Cancer Program: Lessons Learned from 7 Years of Growth and Progress

Emily Haines, Lauren Lux, Jacob Stein et al. · Journal of Adolescent and Young Adult Oncology · 2023 · 13 citations · Full text

Medicine, Oncology, Pediatrics +9

Phase II Study of High Dose Cytarabine Followed By Pembrolizumab in Relapsed/Refractory Acute Myeloid Leukemia (AML)

Joshua F. Zeidner, Benjamin G. Vincent, Anastasia Ivanova et al. · Blood · 2017 · 10 citations

Medicine, Oncology, Pharmacotherapy +15

1–4 of 4